Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5 - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4330

Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5

Analysis of ileum neuroendocrine tumor (NET) cell line CNDT2.5 treated with octreotide for up to 16 months. Somatostain analog octreotide is used to treat NET patients. Results provided insight into molecular basis of successful octreotide therapy or the development of drug resistance in NETs.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 5 cell line, 3 time sets

Platform:: GPL6244
Series:: GSE24358
8 Samples

Download data: CEL, CHP

DataSet

Accession:: GDS4330

ID:: 4330

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 87938082) (1)
GEO DataSets
Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
Accession: GDS4330

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets